Načítá se...
Engineering and Expression of a Chimeric Transferrin Receptor Monoclonal Antibody for Blood–Brain Barrier Delivery in the Mouse
Protein therapeutics may be delivered across the blood–brain barrier (BBB) by genetic fusion to a BBB molecular Trojan horse. The latter is an endogenous peptide or a peptidomimetic monoclonal antibody (MAb) against a BBB receptor, such as the insulin receptor or the transferrin receptor (TfR). Fusi...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2729652/ https://ncbi.nlm.nih.gov/pubmed/18942151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bit.22135 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|